When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
Sara VolpeCosimo TortorellaVincenzo SolfrizziGiuseppina PiazzollaPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2021)
In the era of new cardioprotective antidiabetic drugs, we believe the importance of the C-peptide assay should be re-evaluated in order to avoid misdiagnosis and to improve the therapeutic approach to T2D.